Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,558 JPY | +2.16% | +3.45% | -7.59% |
May. 02 | Poseida Therapeutics to Receive Up to $600 Million in Cancer Gene Therapy Research, Development Deal With Xyphos | MT |
May. 01 | Malin Corp investee signs agreement with Astellas Pharma | AN |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.59% | 18.27B | |
+21.85% | 546B | |
-4.77% | 359B | |
+16.97% | 323B | |
+5.69% | 290B | |
+13.68% | 234B | |
+3.65% | 198B | |
-11.12% | 194B | |
+8.08% | 167B | |
-3.40% | 157B |
- Stock Market
- Equities
- 4503 Stock
- News Astellas Pharma Inc.
- Astellas Pharma Cuts Attributable Profit Forecast for Fiscal Year Ended March